Vol. 19 No. 4 (2015)
HEART RHYTHM DISORDERS

Influence of renal denervation on atrial tachyarrhythmia recurrence in patients with resistant hypertension and atrial fibrillation

PDF (Русский)
  • D. Zamanov,
  • A. Dmitriev,
  • S. Antonov,
  • L. Pristromova,
  • E. Ivanitskaya,
  • A. Pustovoitov,
  • E. Korchagin,
  • S. Artemenko,
  • V. Shabanov,
  • A. Romanov,
  • E. Pokushalov
D. Zamanov
Regional Clinical Hospital, 3a Partizan Zhelezniak St., 660022 Krasnoyarsk, Russian Federation
A. Dmitriev
Regional Clinical Hospital, 3a Partizan Zhelezniak St., 660022 Krasnoyarsk, Russian Federation
S. Antonov
Regional Clinical Hospital, 3a Partizan Zhelezniak St., 660022 Krasnoyarsk, Russian Federation
L. Pristromova
Regional Clinical Hospital, 3a Partizan Zhelezniak St., 660022 Krasnoyarsk, Russian Federation
E. Ivanitskaya
Regional Clinical Hospital, 3a Partizan Zhelezniak St., 660022 Krasnoyarsk, Russian Federation
A. Pustovoitov
Regional Clinical Hospital, 3a Partizan Zhelezniak St., 660022 Krasnoyarsk, Russian Federation
E. Korchagin
Regional Clinical Hospital, 3a Partizan Zhelezniak St., 660022 Krasnoyarsk, Russian Federation
S. Artemenko
Academician Ye. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health Care of Russian Federation, 15 Rechkunovskaya St., 630055 Novosibirsk, Russian Federation
V. Shabanov
Academician Ye. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health Care of Russian Federation, 15 Rechkunovskaya St., 630055 Novosibirsk, Russian Federation
A. Romanov
Academician Ye. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health Care of Russian Federation, 15 Rechkunovskaya St., 630055 Novosibirsk, Russian Federation
E. Pokushalov
Academician Ye. Meshalkin Novosibirsk Research Institute of Circulation Pathology, Ministry of Health Care of Russian Federation, 15 Rechkunovskaya St., 630055 Novosibirsk, Russian Federation
DOI: https://doi.org/10.21688/1681-3472-2015-4-91-98

Published 2016-01-11

Keywords

  • atrial fibrillation,
  • renal artery denervation,
  • renal denervation,
  • drug-resistant hypertension

How to Cite

Zamanov, D., Dmitriev, A., Antonov, S., Pristromova, L., Ivanitskaya, E., Pustovoitov, A., Korchagin, E., Artemenko, S., Shabanov, V., Romanov, A., & Pokushalov, E. (2016). Influence of renal denervation on atrial tachyarrhythmia recurrence in patients with resistant hypertension and atrial fibrillation. Patologiya Krovoobrashcheniya I Kardiokhirurgiya, 19(4), 91–98. https://doi.org/10.21688/1681-3472-2015-4-91-98

Copyright (c) 2016 Zamanov D.A., Dmitriev A.Yu., Antonov S.I., Pristromova L.V., Ivanitskaya E.E., Pustovoitov A.V., Korchagin E.E., Artemenko S.N., Shabanov V.V., Romanov A.B., Pokushalov E.A.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Abstract

Objective. The aim of this prospective randomized study was to assess the impact of renal artery denervation on patients with refractory AF and drug resistant hypertension, for whom pulmonary vein isolation (PVI) was recommended.
Methods. Patients with symptomatic paroxysmal or persistent AF refractory to ≥2 antiarrhythmic drugs and drug-resistant hypertension (systolic blood pressure >160 mm Hg despite triple drug therapy) were eligible for enrolment. 50 consenting patients were randomized to PVI only (n = 25) or PVI with renal artery denervation (n = 25). All patients were followed during 18 months to assess sinus rhythm stability and to monitor blood pressure changes.
Results. Out of 25, 16 (64%) patients treated with PVI and renal denervation versus 6 (24%) of the 25 patients in the PVI-only group (p=0.004, log-rank test) were AF-free at 18-month post ablation follow-up. At the end of follow-up, significant reductions in systolic (–27±4 mm Hg) and diastolic blood pressure (–11±2 mm Hg) were observed in patients treated with PVI with renal denervation, with no significant changes in the PVI only group.
Conclusion. Renal artery denervation combined with PVI reduces AF recurrence and systolic/diastolic blood pressure, as compared with conventional AF ablation, in patients with drug-resistant hypertension and AF.

PDF (Русский)

References

  1. Krum H., Schlaich M., Whitbourn R., Sobotka P.A., Sadowski J., Bartus K., Kapelak B., Walton A., Sievert H., Thambar S., Abraham W.T., Esler M. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study // Lancet. 2009. Vol. 373. P. 1275–81.
  2. Esler M.D., Krum H., Sobotka P.A., Schlaich M.P., Schmieder R.E., Bohm M. Renal sympathetic denervation in patients with treatmentresistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial // Lancet. 2010. Vol. 376. № 9756. P. 1903–9.
  3. Schlaich M.P., Sobotka P.A., Krum H., Whitbourn R., Walton A., Esler M.D. Renal denervation as a therapeutic approach for hypertension: novel implications for an old concept // Hypertension. 2009. Vol. 54. P 1195–1201.
  4. Calhoun D.A., Jones D., Textor S., Goff D.C., Murphy T.P., Toto R.D., White A., Cushman W.C., White W., Sica D., Ferdinand K., Giles T.D., Falkner B., Carey R.M. Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research // Hypertension. 2008. Vol. 51. P. 1403–1419.
  5. Tsioufis C., Kordalis A., Flessas D., Anastasopoulos I., Tsiachris D., Papademetriou V., Stefanadis C. Pathophysiology of resistant hypertension: the role of sympathetic nervous system // Int. J. Hypertens. 2011. Vol. 642. P. 4–16.
  6. Gewirtz J.R., Bisognano J.D. Catheter-based renal sympathetic denervation: A targeted approach to resistant hypertension // Cardiol. J. 2011. Vol. 18. P. 97–102.
  7. Schlaich M.P., Sobotka P.A., Krum H., Lambert E., Esler M.D. Renal sympathetic-nerve ablation for uncontrolled hypertension // N. Engl. J. Med. 2009. Vol. 361. № 9. P. 932–4.
  8. Schlaich M.P., Socratous F., Hennebry S., Eikelis N., Lambert E.A., Straznicky N., Esler M.D., Lambert G.W. Sympathetic activation in chronic renal failure // J. Am. Soc. Nephrol. 2009. Vol. 20. № 5. P. 933–9.
  9. Pokushalov E., Romanov A., Corbucci G., Artyomenko S., Baranova V., Turov A., Shirokova N., Karaskov A., Mittal S., Steinberg J.S. A randomized comparison of pulmonary vein isolation with versus without concomitant renal artery denervation in patients with refractory symptomatic atrial fibrillation and resistant hypertension // J. Am. Coll. Cardiol. 2012. Vol. 60. № 13. P. 1163–70.
  10. Покушалов Е.А., Романов А.Б., Артеменко С.Н., Стенин И.Г., Туров А.Н., Якубов А.А., Лосик Д.В., Баранова В.В., Байрамова С.А., Караськов А.М. Циркулярная изоляция легочных вен в сочетании с денервацией почечных артерий у пациентов с фибрилляцией предсердий и резистентной артериальной гипертензией // Вестник Аритмологии. 2013. № 71. С. 19–26.
  11. Заманов Д.А., Дмитриев А.Ю., Шильников Н.В., Иваницкая Э.Э., Романов А.Б., Покушалов Е.А. Модуляция автономной нервной системы с помощью денервации почечных артерий для лечения фибрилляции предсердий // Патология кровообращения и кардиохирургия. 2014. № 4. С. 113–122.
  12. Pokushalov E., Romanov A., Corbucci G., Artyomenko S., Turov A., Shirokova N., Karaskov A. Ablation of Paroxysmal and Persistent Atrial Fibrillation: 1-Year Follow-Up Through Continuous Subcutaneous Monitoring // J. Cardiovasc. Electrophysiol. 2011. Vol. 22. P. 369–75.
  13. Mancia G., Grassi G. Joint National Committee VII and European Society of Hypertension/European Society of Cardiology guidelines for evaluating and treating hypertension: a two-way road? European Society of Hypertension; European Society of Cardiology // J. Am. So.c Nephrol. 2005. Vol. 16. Suppl. 1. P. S74–7.
  14. Symplicity HTN-1-4 Investigators. Catheter-based renal sympathetic denervation for resistant hypertension: durability of blood pressure reduction out to 24 months // Hypertension. 2011. Vol. 57. P. 911–7.
  15. Miyazaki S., Kuwahara T., Kobori A., Takahashi Y., Takei A., Sato A., Isobe M., Takahashi A. Preprocedural predictors of atrial fibrillation recurrence following pulmonary vein antrum isolation in patients with paroxysmal atrial fibrillation: long-term follow-up results // J. Cardiovasc. Electrophysiol. 2011. Vol. 22. № 6. P. 621–5.
  16. Letsas K.P., Weber R., Burkle G., Mihas C.C., Minners J., Kalusche D., Arentz T. Preablative predictors of atrial fibrillation recurrence following pulmonary vein isolation: the potential role of inflammation // Europace. 2009. Vol. 11. № 2. P. 158–63.
  17. Lau D.H., Mackenzie L., Kelly D.J., Psaltis P.J., Brooks A.G., Worthington M., Rajendram A., Kelly D.R., Zhang Y., Kuklik P., Nelson A.J., Wong C.X., Worthley S.G., Rao M., Faull R.J., Edwards J., Saint D.A., Sanders P. Hypertension and atrial fibrillation: evidence of progressive atrial remodeling with electrostructural correlate in a conscious chronically instrumented ovine model // Heart Rhythm. 2010. Vol. 7. № 9. P. 1282–90.
  18. Шабанов В.В., Романов А.Б., Артеменко С.Н., Елесин Д.В., Стрельников А.Г., Байрамова СА, Покушалов ЕА. Определение оптимального подхода в лечении пациентов с ранними рецидивами фибрилляции предсердий после первой процедуры аблации // Патология кровообращения и кардиохирургия. 2013. № 1. С. 113–122.